Ignite Creation Date:
2024-05-05 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00539201
Status:
TERMINATED
Last Update Posted:
2010-10-19
First Post:
2007-10-02
Brief Title:
GSK706769 A First Time in Human Study For Males and Females
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Double-Blind Parallel Randomized Placebo-Controlled Single and Repeat Dose Escalation Study to Investigate the Safety Tolerability and Pharmacokinetics of GSK706769 in Healthy Male and Female Subjects
Status:
TERMINATED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine safety tolerability and pharmacokinetics of GSK706769
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None